Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Inspire Medical Systems, Inc. (NYSE:INSPGet Free Report) have received a consensus rating of “Moderate Buy” from the twelve research firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $233.58.

Several equities analysts recently weighed in on INSP shares. Wells Fargo & Company increased their price target on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Piper Sandler restated an “overweight” rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Truist Financial reiterated a “buy” rating and issued a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their target price for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th.

View Our Latest Report on INSP

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. True Wealth Design LLC purchased a new position in shares of Inspire Medical Systems during the third quarter worth about $30,000. Farther Finance Advisors LLC lifted its position in Inspire Medical Systems by 1,158.3% during the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock valued at $32,000 after purchasing an additional 139 shares during the last quarter. GAMMA Investing LLC grew its stake in Inspire Medical Systems by 559.3% in the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after buying an additional 151 shares in the last quarter. Quarry LP increased its holdings in shares of Inspire Medical Systems by 105.4% in the 2nd quarter. Quarry LP now owns 343 shares of the company’s stock worth $46,000 after buying an additional 176 shares during the last quarter. Finally, Daiwa Securities Group Inc. purchased a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $53,000. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Performance

Shares of INSP stock opened at $175.75 on Tuesday. Inspire Medical Systems has a 52-week low of $123.00 and a 52-week high of $257.40. The company has a 50-day simple moving average of $191.37 and a two-hundred day simple moving average of $184.30. The company has a market capitalization of $5.27 billion, a price-to-earnings ratio of 164.25 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSPGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Inspire Medical Systems’s revenue was up 32.6% on a year-over-year basis. During the same period last year, the business posted ($0.29) earnings per share. On average, sell-side analysts forecast that Inspire Medical Systems will post 1.33 EPS for the current fiscal year.

About Inspire Medical Systems

(Get Free Report

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Featured Stories

Analyst Recommendations for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.